Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Squinto Stephen P
Relationship:   Director, 10% Owner
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   238,160    

Indirect Shares

   6,290,493      
Direct Value   $19,437,710    

Indirect Value

   $19,013,945      
Total Shares   6,528,653      
Total Value   $38,451,655      


Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0 Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN EVP, Chief Global Ops.... 2014-10-27 106,508 2013-10-28 104,186    Premium*  
            Springworks Therapeutics, Inc. SWTX Director, 10% Owner 2022-05-19 131,652 2022-05-19 6,186,307    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-01-10 4 S $69.02 $49,142 D/D (712) 16,060 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-01-28 4 S $94.50 $67,568 D/D (715) 85,264 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-03-12 4 AS $37.15 $28,160 D/D (758) 15,514 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-01-29 4 S $94.32 $72,343 D/D (767) 84,497 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-08-05 4 S $116.87 $99,573 D/D (852) 106,490 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-02-03 4 S $157.14 $133,883 D/D (852) 102,216 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2012-12-13 5 GA $0.00 $0 I/I 951 108,942 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-09-13 4 S $114.37 $114,370 I/I (1,000) 105,490 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-10-28 4 S $123.89 $123,890 I/I (1,000) 104,186 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-31 4 AS $105.01 $106,585 D/D (1,015) 85,979 0 -
SWTX Springworks Therapeutics,... Director   –       •       •   2021-04-15 4 AS $75.01 $79,291 D/D (1,057) 145,160 0 -
SWTX Springworks Therapeutics,... Director   –       •       •   2021-05-20 4 A $0.00 $0 D/D 1,106 126,834 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-01-29 4 S $133.21 $149,039 D/D (1,118) 103,068 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-07-30 4 S $110.86 $124,163 D/D (1,120) 107,342 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-09-23 4 A $0.00 $0 D/D 1,250 78,851 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2011-01-27 4 S $84.70 $112,651 D/D (1,330) 32,917 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-01-16 4 S $36.81 $49,620 D/D (1,348) 25,590 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-01-11 4 S $47.67 $69,837 D/D (1,465) 26,786 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-02-07 4 S $155.55 $252,030 D/D (1,620) 102,943 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-02-10 4 S $167.31 $273,552 D/D (1,635) 101,308 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-08-04 4 S $157.42 $261,632 D/D (1,662) 106,944 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2004-12-17 4 AS $25.00 $45,250 D/D (1,810) 26,316 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-03-11 4 GD $31.67 $62,897 D/D 1,986 31,285 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-02-04 4 S $95.66 $246,081 D/D (2,572) 81,925 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-03-16 4 S $34.25 $93,057 D/D (2,717) 28,568 0 -
  148  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us